Investment pillar

Apply for Healthcare Funding

Apply now

chip

Active Fund

OneVentures Healthcare Fund III

Licenced under the Commonwealth Government’s Biomedical Translation Fund (BTF) programme, the Fund Invests in therapeutics, devices and diagnostics at or near clinical development with a clear commercial, regulatory and reimbursement pathway.

More information

The OneVentures Healthcare Fund is

Launched in 2016 raising $170M

The Fund is targeting therapeutics, devices and
diagnostics at or near clinical development with a clear commercial, regulatory and reimbursement pathway; and well-defined value
inflection and exit points on deal entry.

Licenced under the Commonwealth Government’s (BTF) programme

The BTF programme was established to provide a pool of public and private funds for investment in promising biomedical innovations with commercialisation potential, managed by leading Australian venture firms. OneVentures was granted an $85 million license supported by matching capital from its private investor network. The BTF funding provides benefits to investors both during the investment phase and on realisation.

Invests $10 to $20 million per company in Australian domiciled companies

The OneVentures team will provide support to drive these opportunities through the clinical, regulatory and reimbursement processes to achieve prominence in global markets.

Criteria for Entrepreneurs

To fit our mandate, your company must be:

  • Domiciled in Australia, and planning to carry out substantial
    R&D in Australia
  • Developing either therapeutics, medical devices, or
    diagnostics
  • Clinical stage or less than a year from first in human studies
  • Privately owned and unlisted

Apply now

Healthcare Investment cases
Testimonials
format_quote
Ventured. Gained.

We embrace the power of ideas, but we invest in more than promise.

Apply now

clear Close
Apply for

Healthcare Investment

"*" indicates required fields

decor decor decor
decor decor decor decor decor
clear Close